Based on these findings, it was hypothesized that MLKL may undergo cleavage in response to death triggers, such as bortezomib, MG132 or DHA/EPA in MM cells and the resultant C-terminal fragment (~35 kDa) maybe quickly be degraded by the ubiquitin–proteasome system. This evidence concerns the gene MLKL and Miyoshi myopathy.